Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
AEZSDelisted Stock | USD 6.14 0.08 1.29% |
Slightly above 61% of AEZS Old's investor base is looking to short. The analysis of current outlook of investing in AEZS Old suggests that many traders are alarmed regarding AEZS Old's prospects. AEZS Old's investing sentiment can be driven by a variety of factors including economic data, AEZS Old's earnings reports, geopolitical events, and overall market trends.
AEZS |
ISS states in its Aeterna Zentaris FOR recommendation that on balance, the deal has strong strategic merit, third party solicitation was unable to...
Read at globenewswire.com
AEZS Old Fundamental Analysis
We analyze AEZS Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AEZS Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AEZS Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
AEZS Old is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
AEZS Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AEZS Old stock to make a market-neutral strategy. Peer analysis of AEZS Old could also be used in its relative valuation, which is a method of valuing AEZS Old by comparing valuation metrics with similar companies.
Peers
AEZS Old Related Equities
IBIO | Ibio | 0.37 | ||||
MBRX | Moleculin Biotech | 0.56 | ||||
PULM | Pulmatrix | 4.31 | ||||
ATXI | Avenue Therapeutics | 4.62 | ||||
ADIL | Adial Pharmaceuticals | 4.67 | ||||
RNAZ | Transcode Therapeutics | 4.99 | ||||
RVPH | Reviva Pharmaceuticals | 6.50 | ||||
JAGX | Jaguar Animal | 7.63 | ||||
BPTH | Bio Path | 8.41 | ||||
TNXP | Tonix Pharmaceuticals | 10.34 | ||||
ADTX | Aditxt | 10.53 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in AEZS Stock
If you are still planning to invest in AEZS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AEZS Old's history and understand the potential risks before investing.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |